Orbimed Advisors Lowered Its Holding in Merck & Co (MRK) as Share Price Declined; Delphi Management Maintains Position in Apogee Enterprises (APOG)

April 25, 2018 - By wolcottdaily

Apogee Enterprises, Inc. (NASDAQ:APOG) Logo

Samuel Isaly decreased its stake in Merck & Co Inc (MRK) by 33.93% based on its latest 2017Q4 regulatory filing with the SEC. Orbimed Advisors Llc sold 1.86 million shares as the company’s stock declined 4.63% with the market. The hedge fund run by Samuel Isaly held 3.63M shares of the health care company at the end of 2017Q4, valued at $204.00 million, down from 5.49 million at the end of the previous reported quarter. Orbimed Advisors Llc who had been investing in Merck & Co Inc for a number of months, seems to be less bullish one the $161.81B market cap company. The stock decreased 0.27% or $0.16 during the last trading session, reaching $60.09. About 13.33M shares traded or 4.39% up from the average. Merck & Co., Inc. (NYSE:MRK) has declined 14.94% since April 25, 2017 and is downtrending. It has underperformed by 26.49% the S&P500.

Delphi Management Inc increased its stake in Apogee Enterprises (APOG) by 89.24% based on its latest 2017Q4 regulatory filing with the SEC. Delphi Management Inc bought 25,194 shares as the company’s stock declined 0.48% with the market. The institutional investor held 53,427 shares of the capital goods company at the end of 2017Q4, valued at $2.44 million, up from 28,233 at the end of the previous reported quarter. Delphi Management Inc who had been investing in Apogee Enterprises for a number of months, seems to be bullish on the $1.18B market cap company. The stock decreased 2.53% or $1.08 during the last trading session, reaching $41.56. About 204,663 shares traded. Apogee Enterprises, Inc. (NASDAQ:APOG) has declined 23.35% since April 25, 2017 and is downtrending. It has underperformed by 34.90% the S&P500.

Investors sentiment decreased to 1.17 in 2017 Q4. Its down 0.38, from 1.55 in 2017Q3. It dropped, as 27 investors sold APOG shares while 60 reduced holdings. 37 funds opened positions while 65 raised stakes. 27.00 million shares or 0.34% less from 27.09 million shares in 2017Q3 were reported. Sei Company owns 44,706 shares. Hcsf Mgmt Ltd Llc, a California-based fund reported 80,000 shares. Vanguard Grp reported 2.68 million shares stake. Riverhead Capital Management Ltd Liability Co has invested 0.01% in Apogee Enterprises, Inc. (NASDAQ:APOG). Point72 Asset Mngmt LP invested in 0.01% or 74,300 shares. 7,450 were reported by Mason Street Advsrs Limited Liability. Renaissance Gp Limited Co has 0.01% invested in Apogee Enterprises, Inc. (NASDAQ:APOG) for 6,613 shares. Us Bancorporation De stated it has 55,610 shares or 0.01% of all its holdings. Goldman Sachs Group Inc has 0% invested in Apogee Enterprises, Inc. (NASDAQ:APOG). Wells Fargo Co Mn reported 469,271 shares or 0.01% of all its holdings. The Illinois-based Ubs Asset Mgmt Americas Inc has invested 0% in Apogee Enterprises, Inc. (NASDAQ:APOG). Macquarie Group reported 14,023 shares. Moreover, State Street Corporation has 0% invested in Apogee Enterprises, Inc. (NASDAQ:APOG) for 1.14 million shares. Wellington Shields Mngmt Llc owns 24,900 shares for 0.18% of their portfolio. Moreover, New York State Teachers Retirement Systems has 0.01% invested in Apogee Enterprises, Inc. (NASDAQ:APOG) for 66,722 shares.

Delphi Management Inc, which manages about $966.00 million and $175.55M US Long portfolio, decreased its stake in Abbvie Inc (NYSE:ABBV) by 5,204 shares to 27,745 shares, valued at $2.68 million in 2017Q4, according to the filing. It also reduced its holding in Thor Industries Inc (NYSE:THO) by 6,111 shares in the quarter, leaving it with 18,500 shares, and cut its stake in Lam Research Corp (NASDAQ:LRCX).

Among 3 analysts covering Apogee Enterprises (NASDAQ:APOG), 2 have Buy rating, 1 Sell and 0 Hold. Therefore 67% are positive. Apogee Enterprises had 5 analyst reports since August 26, 2015 according to SRatingsIntel. The company was downgraded on Wednesday, April 4 by Goldman Sachs. Zacks downgraded the shares of APOG in report on Wednesday, August 26 to “Buy” rating.

Since January 25, 2018, it had 0 insider purchases, and 1 sale for $101,330 activity.

Orbimed Advisors Llc, which manages about $6.70B and $7.91 billion US Long portfolio, upped its stake in Shire Plc (NASDAQ:SHPG) by 172,508 shares to 272,508 shares, valued at $42.27 million in 2017Q4, according to the filing. It also increased its holding in Bristol Myers Squibb Co (NYSE:BMY) by 538,000 shares in the quarter, for a total of 688,000 shares, and has risen its stake in Verona Pharma Plc.

Investors sentiment decreased to 0.94 in 2017 Q4. Its down 0.12, from 1.06 in 2017Q3. It fall, as 94 investors sold MRK shares while 631 reduced holdings. 123 funds opened positions while 558 raised stakes. 1.93 billion shares or 1.34% less from 1.96 billion shares in 2017Q3 were reported. Edgar Lomax Va stated it has 0.53% of its portfolio in Merck & Co., Inc. (NYSE:MRK). Moreover, Cubic Asset Management Ltd Limited Liability Company has 0.21% invested in Merck & Co., Inc. (NYSE:MRK). Fjarde Ap holds 0.65% or 765,446 shares. Comml Bank Of The West holds 0.22% or 31,075 shares. Motco has 57,258 shares for 0.33% of their portfolio. 873,059 are owned by Alps Advisors. Dean Inv Associate Lc owns 26,117 shares. Legg Mason Asset (Japan) Ltd has 12,800 shares for 0.43% of their portfolio. Employees Retirement Association Of Colorado has invested 0.82% in Merck & Co., Inc. (NYSE:MRK). Tru Of Vermont has invested 0.48% in Merck & Co., Inc. (NYSE:MRK). Moreover, Semper Augustus Invs Limited Liability Company has 1.8% invested in Merck & Co., Inc. (NYSE:MRK). Brookstone Cap reported 103,594 shares. 962,311 were reported by Connor Clark Lunn Investment Mgmt. 5,093 were accumulated by Boston Rech And Mngmt. Sphera Funds Mgmt Ltd stated it has 425,000 shares.

Apogee Enterprises, Inc. (NASDAQ:APOG) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 wolcottdaily

Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:








Recent Posts